Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.3K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

85.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of CDDO‑TFEA on non‑small cell lung cancer growth, apoptosis, and stemness via the MEK/ERK pathway.

Journal of cancer research and clinical oncology·2026
Same author

The MAPK/ATF3/ASNS axis drives amino acid metabolic reprogramming to promote NSCLC survival under glucose deprivation.

Journal of translational medicine·2026
Same author

Diagnostic comparisons of PTSD and complex PTSD in clinical adolescents: Detection rates and ACEs as risk factors.

European journal of psychotraumatology·2026
Same author

Research on the decision-making of high-tech manufacturing enterprises for energy conservation and emission reduction driven by industrial green microgrids under the green credit regulatory system.

Scientific reports·2026
Same author

RTA-408 induces JNK-dependent apoptosis and autophagy in breast cancer cells.

Oncology letters·2026
Same author

Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer's Disease-Like Model.

Molecular neurobiology·2026

Related Experiment Video

Updated: Jan 10, 2026

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
08:11

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

Published on: September 26, 2011

23.6K

RTA-408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma.

Hung-Pei Tsai1,2, Hao Qin3, Yoon Bin Chong1,4

  • 1Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

The Kaohsiung Journal of Medical Sciences
|November 29, 2025
PubMed
Summary

RTA-408, a novel compound, shows promise in treating glioblastoma (GBM) by activating the JNK pathway. It reduces GBM cell growth, migration, and enhances radiosensitivity, offering a potential new therapy for this aggressive brain cancer.

Keywords:
apoptosisbrain neoplasmscell proliferationneoplasm invasivenessnuclear factor erythroid 2‐related factor

More Related Videos

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

16.9K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.4K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
08:11

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

Published on: September 26, 2011

23.6K
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

16.9K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.4K

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options.
  • RTA-408, a synthetic triterpenoid, has shown anti-cancer effects, but its role in GBM was unknown.

Purpose of the Study:

  • To investigate the therapeutic potential of RTA-408 in glioblastoma.
  • To explore the role of the JNK pathway in RTA-408's anti-GBM effects.

Main Methods:

  • GBM cell lines (GBM8401, A172) were treated with RTA-408.
  • Assessed cell viability, apoptosis, migration, and radiosensitivity.
  • Western blot analyzed JNK pathway and EMT markers.
  • Intracranial xenograft models evaluated tumor growth suppression with RTA-408 and radiotherapy.

Main Results:

  • RTA-408 reduced GBM cell viability, induced apoptosis, and inhibited migration, linked to JNK pathway activation.
  • JNK inhibition reversed RTA-408's anti-tumor effects.
  • RTA-408 enhanced radiosensitivity and suppressed tumor growth in vivo, especially combined with radiotherapy.

Conclusions:

  • RTA-408 demonstrates significant anti-tumor and radiosensitizing effects in glioblastoma through JNK pathway activation.
  • RTA-408 represents a potential novel therapeutic strategy for GBM treatment.